Accéder au contenu
Merck
  • Optical mapping of sarcoplasmic reticulum Ca2+ in the intact heart: ryanodine receptor refractoriness during alternans and fibrillation.

Optical mapping of sarcoplasmic reticulum Ca2+ in the intact heart: ryanodine receptor refractoriness during alternans and fibrillation.

Circulation research (2014-02-27)
Lianguo Wang, Rachel C Myles, Nicole M De Jesus, Alex K P Ohlendorf, Donald M Bers, Crystal M Ripplinger
RÉSUMÉ

Sarcoplasmic reticulum (SR) Ca(2+) cycling is key to normal excitation-contraction coupling but may also contribute to pathological cardiac alternans and arrhythmia. To measure intra-SR free [Ca(2+)] ([Ca(2+)]SR) changes in intact hearts during alternans and ventricular fibrillation (VF). Simultaneous optical mapping of Vm (with RH237) and [Ca(2+)]SR (with Fluo-5N AM) was performed in Langendorff-perfused rabbit hearts. Alternans and VF were induced by rapid pacing. SR Ca(2+) and action potential duration (APD) alternans occurred in-phase, but SR Ca(2+) alternans emerged first as cycle length was progressively reduced (217±10 versus 190±13 ms; P<0.05). Ryanodine receptor (RyR) refractoriness played a key role in the onset of SR Ca(2+) alternans, with SR Ca(2+) release alternans routinely occurring without changes in diastolic [Ca(2+)]SR. Sensitizing RyR with caffeine (200 μmol/L) significantly reduced the pacing threshold for both SR Ca(2+) and APD alternans (188±15 and 173±12 ms; P<0.05 versus baseline). Caffeine also reduced the magnitude of spatially discordant SR Ca(2+) alternans, but not APD alternans, the pacing threshold for discordance, or threshold for VF. During VF, [Ca(2+)]SR was high, but RyR remained nearly continuously refractory, resulting in minimal SR Ca(2+) release throughout VF. In intact hearts, RyR refractoriness initiates SR Ca(2+) release alternans that can be amplified by diastolic [Ca(2+)]SR alternans and lead to APD alternans. Sensitizing RyR suppresses spatially concordant but not discordant SR Ca(2+) and APD alternans. Despite increased [Ca(2+)]SR during VF, SR Ca(2+) release was nearly continuously refractory. This novel method provides insight into SR Ca(2+) handling during cardiac alternans and arrhythmia.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Caféine, anhydrous, 99%, FCC, FG
USP
Caféine, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Isoprenaline hydrochloride
Sigma-Aldrich
Caféine, powder, ReagentPlus®
Supelco
Caféine, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Caféine, United States Pharmacopeia (USP) Reference Standard
Supelco
Caffeine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Caféine, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Caféine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Caféine, Sigma Reference Standard, vial of 250 mg
Supelco
Schmelzpunktstandard 235-237°C, analytical standard
Supelco
Caffeine solution, analytical standard, 1.0 mg/mL in methanol
Supelco
Caféine, traceable to primary standards (LGC)
Sigma-Aldrich
Caféine, anhydrous, tested according to Ph. Eur.
Sigma-Aldrich
Caféine, meets USP testing specifications, anhydrous
Sigma-Aldrich
Caféine, BioXtra
Caféine, European Pharmacopoeia (EP) Reference Standard
Caféine, European Pharmacopoeia (EP) Reference Standard
Isoprenaline sulfate, European Pharmacopoeia (EP) Reference Standard
Isoprenaline hydrochloride, European Pharmacopoeia (EP) Reference Standard